ERBB2 and breast carcinoma: As selected examples, targeted disruption of β1-integrins in a mouse model of human breast cancer leads to a dormant phenotype and blocks tumor induction [16] β4 integrins promotes mammary tumorigenesis in vivo via upregulation of ErbB2 signaling.[17].